Company Name: |
Shanghai Hongye Biotechnology Co. Ltd
|
Tel: |
400-9205774 |
Email: |
sales@glpbio.cn |
Products Intro: |
Product Name:XLR11 6-hydroxyindole metabolite CAS:1630022-98-8 Purity:>98% Package:1mg;10mg;50mg;100mg;
|
Company Name: |
ChemeGen(Shanghai) Biotechnology Co.,Ltd.
|
Tel: |
18818260767 |
Email: |
sales@chemegen.com |
Products Intro: |
Product Name:XLR11 6-hydroxyindole metabolite CAS:1630022-98-8 Purity:98% Package:10 mg;50 mg;100 mg;500 mg;1 g;5 g;10 g
|
Company Name: |
Cayman Chemical Company
|
Tel: |
(800) 364-9897 |
Email: |
cayman@caymanchem.com |
Products Intro: |
Product Name:XLR11 6-hydroxyindole metabolite CAS:1630022-98-8
|
|
| XLR11 6-hydroxyindole metabolite Basic information |
Product Name: | XLR11 6-hydroxyindole metabolite | Synonyms: | XLR11 6-hydroxyindole metabolite;OZGNIKIHSWKZFS-UHFFFAOYSA-N;Methanone, [1-(5-fluoropentyl)-6-hydroxy-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)-;1-(5-fluoropentyl)-6-hydroxy-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)-methanone | CAS: | 1630022-98-8 | MF: | C21H28FNO2 | MW: | 345.45 | EINECS: | | Product Categories: | | Mol File: | 1630022-98-8.mol | |
| XLR11 6-hydroxyindole metabolite Chemical Properties |
Boiling point | 484.8±35.0 °C(Predicted) | density | 1.14±0.1 g/cm3(Predicted) | solubility | DMF: 30 mg/ml; DMSO: 30 mg/ml; Ethanol: 30 mg/ml; Ethanol:PBS (pH 7.2) (1:4): 0.2 mg/ml | form | A crystalline solid | pka | 9.82±0.40(Predicted) |
| XLR11 6-hydroxyindole metabolite Usage And Synthesis |
Description | XLR11 is a synthetic cannabinoid (CB) featuring a tetramethylcyclopropyl group, which reportedly confers selectivity for the peripheral CB2 receptor over the central CB1 receptor.1 XLR11 also has an N-(5-fluoropentyl) chain, which increases binding to both CB receptors.2 XLR11 6-hydroxyindole metabolite is an expected minor monohydroxylated urinary metabolite of XLR11.3 The biological and toxicological properties of this compound have not been evaluated. This product is intended for forensic and research applications. | References | 1. Frost, J.M., Dart, M.J., Tietje, K.R., et al. Indol-3-ylcycloalkyl ketones: Effects of N1 substituted indole side chain variations on CB2 cannabinoid receptor activity J. Med. Chem. 53(1),295-315(2010). 2. Makriyannis, A., and Deng, H. Cannabimimetic indole derivatives US7241799B2,(2001). 3. Wintermeyer, A., M?ller, I., Thevis, M., et al. In vitro phase I metabolism of the synthetic cannabimimetic JWH-018 Anal. Bioanal. Chem. 398(5),2141-2153(2010). |
| XLR11 6-hydroxyindole metabolite Preparation Products And Raw materials |
|